THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE

Details for Australian Patent Application No. 2002359353 (hide)

Owner CURAGEN CORPORATION

Inventors GORMAN, Linda; GROSSE, William, M.; GUO, Xiaojia; HACKETT, Craig; JI, Weizhen; KEKUDA, Ramesh; KHRAMTSOV, Nikolai, V.; LEPLEY, Denise, M.; LI, Li; MACDOUGALL, John, R.; MALYANKAR, Uriel, M.; MAZUR, Ann; MCQUEENEY, Kelly; MEZES, Peter, S.; MILLER, Charles, E.; MILLET, Isabelle; MISHRA, Vishnu, S.; PADIGARU, Muralidhara; PATTURAJAN, Meera; PENA, Carol, E., A.; PEYMAN, John, A.; RASTELLI, Luca; RIEGER, Daniel, K.; SHENOY, Suresh, G.; SHIMKETS, Richard, A.; SMITHSON, Glennda; STARLING, Gary; SPYTEK, Kimberley,

Pub. Number AU-A-2002359353

PCT Number PCT/US02/35536

PCT Pub. Number WO2003/040330

Priority 60/338,626 05.11.01 US; 60/336,600 05.12.01 US; 60/338,285 07.12.01 US; 60/341,346 12.12.01 US; 60/341,477 17.12.01 US; 60/341,540 17.12.01 US; 60/342,592 20.12.01 US; 60/344,297 27.12.01 US; 60/344,903 31.12.01 US; 60/373,288 17.04.02 US; 60/380,981 15.05.02 US; 60/381,495 17.05.02 US; 60/383,534 28.05.02 US; 60/383,744 28.05.02 US; 60/383,829 29.05.02 US; 60/384,024 29.05.02 US; 60/401,788 07.08.02 US; 60/406,353 26.08.02 US; 10/287,971 31.10.02 US

Filing date 5 November 2002

Wipo publication date 19 May 2003

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/338,626 05.11.01 US; 60/336,600 05.12.01 US; 60/338,285 07.12.01 US; 60/341,346 12.12.01 US; 60/341,477 17.12.01 US; 60/341,540 17.12.01 US; 60/342,592 20.12.01 US; 60/344,297 27.12.01 US; 60/344,903 31.12.01 US; 60/373,288 17.04.02 US; 60/380,981 15.05.02 US; 60/381,495 17.05.02 US; 60/383,534 28.05.02 US; 60/383,744 28.05.02 US; 60/383,829 29.05.02 US; 60/384,024 29.05.02 US; 60/401,788 07.08.02 US; 60/406,353 26.08.02 US; 10/287,971 31.10.02 US

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002359353

1 June 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002359354-Variable thickness tubular doorbeam

2002359352-ANTISENSE MODULATION OF THYROID HORMONE RECEPTOR INTERACTOR 6 EXPRESSION